Stay updated on Sotorasib in KRAS G12C NSCLC Clinical Trial
Sign up to get notified when there's something new on the Sotorasib in KRAS G12C NSCLC Clinical Trial page.

Latest updates to the Sotorasib in KRAS G12C NSCLC Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedAdded a Locations section with Pennsylvania (Philadelphia) as a trial site and updated the page revision to v3.3.3. Removed the HHS Vulnerability Disclosure link and the older Pennsylvania Locations entry (v3.3.2).SummaryDifference0.3%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check41 days agoChange DetectedThe page shows a new revision tag: v3.3.2, replacing v3.2.0. No substantive changes to trial information are evident.SummaryDifference0.1%

- Check48 days agoChange DetectedThe page no longer displays the government funding status notice; there are no changes to trial details, eligibility criteria, or timelines. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check62 days agoChange DetectedThe new screenshot shows minor layout and styling updates with no substantive changes to the study details (inclusion criteria, primary outcome, or enrollment). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check91 days agoChange DetectedOverall, the page updates to v3.2.0 and adds a government-operating-status notice; the prior v3.1.0 reference was removed.SummaryDifference4%

- Check98 days agoChange DetectedChanged the revision from v3.0.2 to v3.1.0, indicating a minor version update with no other content changes.SummaryDifference0.1%

Stay in the know with updates to Sotorasib in KRAS G12C NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sotorasib in KRAS G12C NSCLC Clinical Trial page.